Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/44456
Title: Characterization of diadenosine tetraphosphate (Ap<inf>4</inf>A) binding sites in cultured chromaffin cells: evidence for a P<inf>2y</inf>site
Authors: Pintor, Jesús
Torres, Magdalena
Castro López-Tarruella, Enrique 
Miras‐Portugal, M. Teresa
UNESCO Clasification: 32 Ciencias médicas
Issue Date: 1991
Publisher: 0007-1188
Journal: British journal of pharmacology 
Abstract: Diadenosine tetraphosphate (Ap4A) a dinucleotide, which is stored in secretory granules, presents two types of high affinity binding sites in chromaffin cells. A Kd value of 8 +/- 0.65 x 10(-11) M and Bmax value of 5420 +/- 450 sites per cell were obtained for the high affinity binding site. A Kd value of 5.6 +/- 0.53 x 10(-9) M and a Bmax value close to 70,000 sites per cell were obtained for the second binding site with high affinity. 2. The diadenosine polyphosphates, Ap3A, Ap4A, Ap5A and Ap6A, displaced [3H]-Ap4A from the two binding sites, the Ki values being 1.0 nM, 0.013 nM, 0.013 nM and 0.013 nM for the very high affinity binding site and 0.5 microM, 0.13 microM, 0.062 microM and 0.75 microM for the second binding site. 3. The ATP analogues displaced [3H]-Ap4A with the potency order of the P2y receptors, adenosine 5'-O-(2 thiodiphosphate) (ADP-beta-S) greater than 5'-adenylyl imidodiphosphate (AMP-PNP) greater than alpha, beta-methylene ATP (alpha, beta-MeATP), in both binding sites. The Ki values were respectively 0.075 nM, 0.2 nM and 0.75 nM for the very high affinity binding site and 0.125 microM, 0.5 microM and 0.9 microM for the second binding site.
URI: http://hdl.handle.net/10553/44456
ISSN: 0007-1188
DOI: 10.1111/j.1476-5381.1991.tb12363.x
Source: British Journal of Pharmacology [ISSN 0007-1188], v. 103, p. 1980-1984
Appears in Collections:Artículos
Show full item record

SCOPUSTM   
Citations

59
checked on Apr 4, 2020

Page view(s)

13
checked on Apr 4, 2020

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.